I'm not expecting a partnership announcement this soon and a CC to just discuss the start of the 534 trial would be underwhelming so, I too, am hoping that we get an SPA tomorrow. Even though the CML approval path is well known, I'd think ariad would want the added security of identifying expectations in advance given the P2 is their pivotal, registration trial.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.